ORMP Share Price Performance
US$2.23
-0.08 (-3.67%)
Price US$2.23
Share PriceUS$2.23
We Think Oramed Pharmaceuticals (NASDAQ:ORMP) Can Afford To Drive Business Growth
May 31
Oramed Pharmaceuticals Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
ORMP Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Oramed Pharmaceuticals Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.59
- 0.65%
- -1,208.10%
- 0%
About ORMP
- Founded
- 2002
- Employees
- n/a
- CEO
- WebsiteView website
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
